BioCentury
ARTICLE | Company News

Shire, ML Labs adhesion deal

October 3, 2001 7:00 AM UTC

Shire (LSE:SHP; SHPGY) received exclusive European manufacturing and marketing rights from ML Laboratories (LSE:MLB) to Adept therapy to prevent adhesions following abdominal surgery. SHP expects to l...